Cryoprotective agents (CPAs) are essential to the cryopreservation process as they protect cells from ice formation, which can lead to irreversible damage. However, one of the biggest challenges in cryopreservation is the potential toxicity of CPAs when used in high concentrations required for effective protection. This toxicity can affect cell viability and functionality - a significant problem when preserving cells for future use.
Advances in cryopreservation technology are leading us to ever more sophisticated solutions. One promising strategy is to combine different CPAs to lower the overall concentration of each one, thereby reducing their toxic effects while achieving robust cryoprotection.
A recent breakthrough is the use of trehalose in combination with glycerol. Trehalose is a disaccharide known for its ability to protect cells under extreme conditions. In combination with glycerol, this combination has been shown to efficiently preserve both the viability and functional integrity of cryopreserved human adipose-derived stem cells.
This approach could redefine the way we look at cell preservation. By optimizing CPA formulations, we can significantly improve the results of cryopreservation, making it more effective and less harmful to cells. The potential applications are diverse and range from biobanks to regenerative medicine. This ensures that preserved cells remain viable and functional when they are needed most.
At Consarctic, we wholeheartedly support and embrace advances in the field of cryopreservation. Innovations such as the combination of CPAs are examples of the groundbreaking advances that are driving our industry forward. While our focus remains on providing state-of-the-art cryopreservation systems and unrivaled services, we recognize the critical importance of these developments to the future of cell preservation. We are committed to ensuring that every sample stored using our technologies has the best possible chance of survival, so that the invaluable potential of biological materials is preserved for years to come.
Consarctic is proud to contribute to the success and reliability of cryopreservation worldwide with its advanced, reliable and precise cryotechnology solutions. Together, we strive for a future where every cryopreserved cell, tissue and organ can be revitalized to its full potential.